
Greg Flynn discusses the advantages, challenges and possible future of CCOs and outlines their role in effective sales strategy development.
Greg Flynn is Regional President, Ashfield US.Greg joined the pharmaceutical industry in 2002, serving in various positions of increasing responsibility, first with GlaxoSmithKine and then Takeda. He joined Ashfield in 2010 as National Head of Sales & Marketing Services U.K. and then worked in operations in both the U.S. and U.K. In 2012 he assumed the position of President, Representative Director, Japan, where his leadership helped Ashfield Japan recognize remarkable growth.
Published: May 7th 2019 | Updated: